Skip to main contentAI and Advanced
/
AMRUTANJAN · NSEBSE SENSEX74,294.96-0.03%BSE |
NIFTY 5023,346.4+0.33%NSE |
NIFTY BANK56,358.7+0.54%NSE |
NIFTY IT28,854.55-1.03%NSE |
NIFTY AUTO27,129-0.11%NSE |
NIFTY FMCG45,466.8-0.23%NSE |
NIFTY PHARMA26,710.1+0.49%NSE |
NIFTY 50022,840.55+0.82%NSE |
AM
NSE · Equity shares · Biotechnology & Drugs4.00 · 0.81%
Amrutanjan Health Care AMRUTANJAN
NSE:INR 495
BSE:INR 494.65
Data quality and coveragePrice, company fundamentals and optional research feeds are tracked separately.
Headline priceLast market snapshot
Company fundamentalsStale · last-known data
Research sections9 of 9 availableMissing source values remain unavailable, never zero-filled.
AI analysis and Advanced tools for AMRUTANJAN
Analysis, reports, chat and Advanced access use the same Rusaka Markets account. The backend remains authoritative for roles, subscriptions, credits and permissions.
Snapshot
Price and key statistics
Reported and computed values remain separate; missing values are not converted to zero.
Previous closeINR 491
Day rangeINR 488.05 — INR 493.4
52-week rangeINR 476.5 — INR 790.95
Volume11,987
Market cap1,576.46
P/E24.65
Fundamental highlightsReported values unless marked as computed
Revenue (INR Cr)502.55
Net Income (INR Cr)57.92
Rev Growth (5 Year %)8.59
EPS Growth (5 Year %)-0.87
P/E Ratio24.65
Book Value127.48
EPS22.31
Price/BV3.88Computed
Research path: Interpret Amrutanjan Health Care's snapshot alongside the wider market dashboard, the financial-statement research guide and the valuation-ratios field guide.
Validated OHLC
Interactive price chart
Crosshair, OHLCV tooltip, indicators, volume, zoom and pan use the same candle API as the advanced workspace.
AMRUTANJANAmrutanjan Health Care1d · INR · NSE
Loading validated candles…
Auditable calculations
Daily technical summary
Calculated from validated daily candles. Descriptive research only.
Calculating technicals…
Indicators describe price behaviour and volatility; they are not a BUY, NEUTRAL or SELL recommendation.
Company reporting
Financial statements
IND AS · INR crore
| Metric | 2026 | 2025 | 2024 |
|---|---|---|---|
| Total Liabilities Shareholders' Equity | 508.89 | 421.39 | 366.87 |
| Cash Equivalents | 33.32 | Not available | Not available |
| Other Liabilities Total | 11.05 | 8.51 | 7.07 |
| Common Stock Total | 2.89 | 2.89 | 2.89 |
| Other Current Assets Total | 14.91 | 2.77 | 0.84 |
| Total Assets | 508.89 | 421.39 | 366.87 |
| Current Portof LT Debt/Capital Leases | 0.35 | 0.4 | 0.33 |
| Total Equity | 370.23 | 326.61 | 288.49 |
| Long Term Investments | 46.24 | 41.7 | 11.78 |
| Retained Earnings(Accumulated Deficit) | 367.34 | 324.78 | 287.21 |
| Total Common Shares Outstanding | 2.89 | 2.89 | 2.89 |
| Tangible Book Valueper Share Common Eq | 127.48 | 112.38 | 98.96 |
| Total Liabilities | 138.66 | 94.77 | 78.38 |
| Total Debt | 1.78 | 2.08 | 1.73 |
| Short Term Investments | 145.41 | 186.4 | 206.76 |
| Cashand Short Term Investments | 178.74 | 196.56 | 210.47 |
| Total Receivables Net | 60.64 | 61.02 | 53.23 |
| Accounts Receivable-Trade Net | 60.64 | 60.39 | 52.32 |
| Property/Plant/Equipment Total-Net | 155.29 | 63.93 | 49.54 |
| Total Current Liabilities | 126.18 | 84.58 | 69.92 |
| Total Inventory | 37.35 | 29.27 | 30.34 |
| Accounts Payable | 70.9 | 69.04 | 55.86 |
| Other Currentliabilities Total | 54.94 | 10.39 | 9.07 |
| Total Long Term Debt | 1.42 | 1.68 | 1.4 |
| Intangibles Net | 1.68 | 1.73 | 2.38 |
| Other Long Term Assets Total | 11.13 | 3.28 | 3.26 |
| Note Receivable-Long Term | 2.91 | 20.08 | 4.23 |
| Total Current Assets | 291.65 | 290.67 | 295.68 |
| Capital Lease Obligations | 1.42 | 1.68 | 1.4 |
| Accumulated Depreciation Total | Not available | -28.7 | -23.49 |
| Accrued Expenses | Not available | 4.75 | 4.65 |
| Prepaid Expenses | Not available | 1.06 | 0.81 |
| Cash | Not available | 10.16 | 3.71 |
| Treasury Stock-Common | Not available | -1.06 | -1.62 |
| Property/Plant/Equipment Total-Gross | Not available | 76.43 | 70.69 |
| Notes Payable/Short Term Debt | Not available | 0 | 0 |
Fundamentals
Valuation and ratios
Valuation
PEG Ratio1.96
Price to Sale Ratio3.14
Growth
Debt 5Yr CAGR %5.77
Margins
Operating Margin 12m12.04
Operating Margin 5y Avg12.64
Net Profit Margin 12m11.52
Net Profit Margin 5y12.07
Yield
Dividend Yield %0.91
Risk and consensus
Source-qualified signals
Risk metrics
Overall RiskBalanced risk
Board Risk30.06
Analyst consensus
Analyst consensus unavailable.
Provider consensus uses a 1 (Strong Buy) to 5 (Strong Sell) score. The payload does not include price targets, so none are inferred from 52-week prices or recommendation percentages.Industry context
Peer comparison
Only peers present in the company profile payload are displayed.
| Company | Price | Market cap | P/E | Research |
|---|---|---|---|---|
| Sun Pharmaceutical Industries | INR 1,936.35 | 4.65 L | 38.4 | — |
| Divi's Laboratories | INR 7,376.6 | 1.96 L | 73.32 | — |
| Torrent Pharmaceuticals | INR 4,981 | 1.69 L | 72.73 | — |
| Cipla | INR 1,405.9 | 1.14 L | 27.57 | — |
| Zydus Lifesciences | INR 1,116.7 | 1.11 L | 21.19 | — |
Shareholding
Ownership
- Promoter
- 46.52%
- FII
- 2.44%
- MF
- 5.82%
- Other
- 45.22%
Company intelligence
Latest relevant news
Source, timestamp and external destination are shown. Provider relevance scores are not available.
Amrutanjan Health Care Ltd is Rated Hold - MarketsMojoMarket news · 13 Jul 2026, 3:22 am
Amrutanjan Health Care Ltd is Rated Hold MarketsMojo
GRANULES Stock Price and Chart — NSE:GRANULES - TradingViewMarket news · 1 Jul 2026, 8:45 am
GRANULES Stock Price and Chart — NSE:GRANULES TradingView
Price to sales forward of Amrutanjan Health Care Limited – NSE:AMRUTANJAN - TradingViewMarket news · 28 Jun 2026, 12:44 am
Price to sales forward of Amrutanjan Health Care Limited – NSE:AMRUTANJAN TradingView
Enterprise value to revenue forward of Amrutanjan Health Care Limited – NSE:AMRUTANJAN - TradingViewMarket news · 26 Jun 2026, 8:15 am
Enterprise value to revenue forward of Amrutanjan Health Care Limited – NSE:AMRUTANJAN TradingView
Amrutanjan Health Care Ltd Technical Momentum Shifts Amid Mixed Market Signals - MarketsMojoMarket news · 24 Jun 2026, 2:12 am
Amrutanjan Health Care Ltd Technical Momentum Shifts Amid Mixed Market Signals MarketsMojo
Amrutanjan Health Care Ltd Faces Bearish Momentum Amid Technical Downgrade - MarketsMojoMarket news · 20 Jun 2026, 2:01 am
Amrutanjan Health Care Ltd Faces Bearish Momentum Amid Technical Downgrade MarketsMojo
Corporate actions
Events
- annual General MeetingPOM
- annual General MeetingPOM
- dividendRs.2.9000 per share(290%)Final Dividend
- board MeetingsAudited Results & Final Dividend
- dividendRs.1.0000 per share(100%)Second Interim Dividend
- board MeetingsQuarterly Results & Interim Dividend
- dividendRs.1.0000 per share(100%)First Interim Dividend
- board MeetingsQuarterly Results & Interim Dividend
Rusaka Markets Community
Discussion and sentiment for Amrutanjan Health Care
Posts are linked to the canonical company record. Community BUY, NEUTRAL and SELL opinions are user-generated, moderated and separate from analyst consensus and Rusaka Markets AI.
Checking your Rusaka Markets account…
Company profile
Business information
What the company does
Amrutanjan Health Care Limited is an India-based company, which is engaged in the business of manufacturing, supplying and sale of products in pain management, congestion management, beverages, and hygiene and services in pain management. Its segments include OTC Products, Women Hygiene, Beverages and Others. The OTC Products segment is engaged in manufacturing products for pain management, congestion management and hygiene. The Women Hygiene includes Comfy Snug Fit, Comfy Snug Fit Extra Long, and Comfy Snug Fit Ultra XL. The Beverages segment is engaged in manufacturing fruit juices and oral hydration drinks. The Others segment includes the pain management center. The Company’s pain management products include Pain Balm Extra Power, Strong Pain Balm, New Maha Strong Pain Balm, Roll on and Advanced Back Pain + Roll-On, among others. Its congestion management products include Relief Cold Rub, Relief Nasal Inhaler, Relief Cough Syrup and Relief Swas Mint.
Company facts
- Industry
- Biotechnology & Drugs
- Sector
- Biotechnology & Drugs
- NSE Code
- AMRUTANJAN
- BSE Code
- 590006
Questions
Stock FAQ
What is the symbol and ISIN of Amrutanjan Health Care?
Amrutanjan Health Care has the symbol AMRUTANJAN and ISIN - INE098F01031.
What is the current price of Amrutanjan Health Care?
Amrutanjan Health Care is currently trading at INR 495.00.
What are the year high and year low of Amrutanjan Health Care?
Amrutanjan Health Care has a year high of INR 790.95 and a year low of INR 476.50.
What is the market capitalization of Amrutanjan Health Care?
Amrutanjan Health Care has a market capitalization of INR 1,576.46 crore.
What is the P/E ratio of Amrutanjan Health Care?
Amrutanjan Health Care has a P/E ratio of 24.65.
What is the dividend yield of Amrutanjan Health Care?
Amrutanjan Health Care has a dividend yield of 0.91%.
How is the financial performance of Amrutanjan Health Care based on revenue, net income, and EPS?
Amrutanjan Health Care has revenue of INR 502.55 crore, net income of INR 57.92 crore, and EPS of INR 22.38.
What is the book value of Amrutanjan Health Care?
Amrutanjan Health Care has a book value of INR 127.48.
What is the debt-to-equity ratio of Amrutanjan Health Care?
Amrutanjan Health Care has a debt-to-equity ratio of NA.
What are the price-to-book and price-to-sales ratios of Amrutanjan Health Care?
Amrutanjan Health Care has a price-to-book ratio of 3.88 and a price-to-sales ratio of 3.14.
Corporate-action adjustment is provider-defined. Rusaka Markets research and computed indicators are not investment advice.